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C BY-NC-Abstract A series of novel N2-[2-chloro-4(3,4,5-trimethoxy phenyl azetidin-1-yl]-N4-(substituted
aryl)-1,3-thiazole-2,4-diamine (4a–g) were synthesized starting from 3,4,5-trimethoxy benzaldehyde
thiosemicarbazone (1). The compound (1) was obtained by condensing 3,4,5-trimethoxy benzalde-
hyde with thiosemicarbazide in methanol. 3,4,5-Trimethoxy benzaldehyde thiosemicarbazone (1) on
treatment with chloracetyl chloride afforded 4-chloro-[2-(3,4,5-trimethoxy benzylidine) hydrazinyl]-
1,3-thiazole (2). Compound (2) was reacted with chloracetyl chloride and triethylamine to obtain
the corresponding 4-chloro-N-[2-chloro-4(3,4,5-trimethoxy phenyl) azetidin-1-yl]-1,3-thiazole-2-
amine (3). Various substitutions on compound 3 with secondary amines yielded series of com-
pounds (4a–g). The newly synthesized compounds were characterized by IR, 1H NMR, elemental
analysis and mass spectral studies. All the compounds were screened for their in vitro antioxidant
properties. The IC50 values of compounds 3 and 4a–g revealed that some of the synthesized com-
pounds were showing potent antioxidant activity.
ª 2011 King Saud University. Production and hosting by Elsevier B.V.Open access under CC BY-NC-ND license.1. Introduction
Reactive oxygen species causes oxidative damage to cells lead-
ing to age related degenerative diseases, cancer and a wide range
of different human diseases (Amarowicz et al., 2010). One
important mechanism of membrane damage is injuries by free.com (V. Jaishree).
y. Production and hosting by
Saud University.
lsevier
ND license.radicals (Shruti et al., 2009). A simple effective way of prevent-
ing diseases is inhibition of oxidative damage. Many natural
as well as synthetic antioxidants are in the market for the treat-
ment of different diseases. (Hadjipavlou-Litina et al., 2010;
Ramarathnam et al., 1995). The major action of antioxidants
in the human diseases is to prevent damage caused by the action
of reactive oxygen species (ROS). ROS such as, nitric oxide,
hydroxyl (OH) and peroxide (ROO) radicals are generated
during excessive metabolism in living organisms and they cause
damage to the normal cells. Several synthetic antioxidants such
as butylated hydroxy anisole, butylated hydroxy toluene are
commercially available and are in use. However, their use is
now prohibited due to their side effects. These observations
argue in favour of the development of alternative synthetic anti-
oxidants. Many thiazoles were found to be associated with var-
ious biological activities, such as antimicrobial (Pattan et al.,
2009; Bzdag˘-Du¨ndar et al., 2007), antifungal (Sibaji Sarkar et
al., 2008), anti-inﬂammatory (Karbasanagouda et al., 2008),
372 V. Jaishree et al.analgesic (Kalkhambkar et al., 2007), antitubercular (Usha
Rani et al., 2008), antitumor (El-Subbagh and Al-Obaid,
1996) and antiprotozoal (Ricardo et al., 2003) properties. These
ﬁndings prompted us to investigate a number of newly synthe-
sized thiazole derivatives for nitric oxide radical scavenging,
hydrogen peroxide scavenging and inhibition of lipid peroxida-
tion and reducing power assays. Furthermore, the in vitro anti-
oxidant effect of thiazole derivatives was compared with
ascorbic acid commonly used as antioxidant.
2. Materials and methods
2.1. Chemistry
Melting points of the synthesized compounds were determined
using the microcontroller based melting point apparatus (Uni-
line) and were found uncorrected. The IR spectra of the syn-
thesized compounds were recorded using KBr pellets in a
Fourier transform IR spectrometer (Shimadzu 8700, SAC Col-
lege of Pharmacy, B.G. Nagar, India) and the frequencies were
recorded in wave numbers. 1H NMR (400 MHz) spectra were
recorded in Amx-400 liquid state NMR spectrometer (Univer-
sity Science Instrument Center, Dharwad, India). Chemical
shifts (d) were reported in parts per million downﬁeld from
internal reference tetramethylsilane (TMS). Mass spectra were
recorded on GCMS in dimethyl sulphoxide (University Science
Instrument Center, Dharwad, India).
2.1.1. Synthesis of 3,4,5-trimethoxy benzaldehyde
thiosemicarbazone (1)
A mixture of 3,4,5-trisubstituted benzaldehyde (0.143 mol),
thiosemicarbazide (0.164 mol) and catalytic amount of concen-
trated sulphuric acid in methanol (50 ml) were reﬂuxed for 5 h.
Then the product was cooled, precipitate was ﬁltered and the
dried residue was recrystallized by using chloroform.
IR (KBr cm1): 1127 (C‚S), 3450 (NH), 1479 (C‚N),
1600 (C‚C), 2975 (C–H). 1H NMR (CDCl3) d (ppm): 7.23
(s, 2H, Ar–H), 3.83 (s, 9H, –OCH3), 3.38 (s, 1H, NH), 2.47
(d, 2H, J= 1.6, –NH2) Mass (GC–MS) [m/z, %]: 269, 252
(31), 221 (43), 178 (31), 147 (31), 117 (33), 84.
2.1.2. Synthesis of 4-chloro-2-[2-(3,4,5-trimethoxy
phenyl)hydrazinyl]-1,3-thiazole (2)
An equimolar mixture of 3,4,5-trimethoxy benzaldehyde thio-
semicarbazone (0.01 mol) and chloracetyl chloride (0.01 mol)
in methanol was reﬂuxed for 4 h. The product was cooled, ﬁl-
tered and the dried residue was puriﬁed by using column
chromatography.
IR (KBr cm1): 1127 (C‚S), 845 (C–Cl), 3445 (NH), 1475
(C‚N), 1588 (C‚C). 1H NMR (CDCl3) d (ppm): 7.23 (s, 2H,
Ar–H), 6.75 (s, 1H, –CH–S), 3.83 (s, 9H, –OCH3), 3.73 (s, 1H,
CH‚N), 2.47 (s, 1H, –NH). Mass (GC–MS) [m/z, %]: 327
(31), 297 (14), 283 (31), 252 (31), 221 (33), 189 (36), 153 (17),
136 (14), 122 (31), 91 (14).
2.1.3. Synthesis of 4-chloro-N-[2-chloro-4(3,4,5-trimethoxy
phenyl) azetidin-1-yl]-1,3 thiazole-2-amine (3)
An equimolar mixture of 4-chloro-2-[2-(3,4,5-trimethoxy
phenyl)hydrazinyl]-1,3-thiazoles (2, 0.01 mol), chloracetyl
chloride (0.01 mol) and triethylamine (0.01 mol) was reﬂuxed
for 8 h in ethanol. Then the product was poured into ice coldwater. The white precipitate was collected by ﬁltration and
recrystallized with methanol.
IR (KBr cm1): 1035 (C‚S), 806, 850 (C–Cl), 1475
(C‚N), 2937 (CH). 1H NMR (CDCl3) d (ppm): 8.63 (s, 1H,
Ar–H), 7.23 (s, 2H, –CH), 2.47 (d, 2H, J= 1.6, –CH2), 4.6
(t, 1H, –CH), 3.83 (s, 9H, –OCH3) 5.2 (s, 1H, –NH). Mass
(GC–MS) [m/z, %]: 388; 374 (14), 343 (31), 307 (36), 293
(14), 252 (36), 224 (33), 193 (31), 162 (32), 146 (16), 132 (14),
101 (31), 86 (14), 44 (42).
2.1.4. Synthesis of various derivatives of N2-[2-chloro-4(3,4,5-
trimethoxy phenyl) azetidin-1-yl)]-N4-(substituted aryl)-1,3-
thioazol-2,4-diamine (4a–g)
An equimolar mixture of 4-chloro-N-[2-chloro-4-(3,4,5-trisub-
stituted phenyl) azetidine]-1,3-thiazol-2-amine (3) (0.01 mol)
and different secondary amines (0.01 mol) was reﬂuxed in eth-
anol for 4–5 h, separately. The resulting product was evapo-
rated to dryness and recrystallized with methanol. The pure
compound was obtained by column chromatography. The
product was checked for purity on TLC.
N2-[2-Chloro-4(3,4,5-trimethoxy phenyl)azetidin-1-yl]-N4-
(2-nitro phenyl)-1,3-thiazole-2,4-diamine (4a): IR (KBr
cm1): 1101 (C–S), 744 (C–Cl), 1569 (C‚C), 3355 (NO),
3481 (NH). 1H NMR (CDCl3) d (ppm): 7.48 (s, 2H, Ar–H),
7.10 (d, 1H, J= 8.4, Ar–H), 6.68 (d, 1H, J= 8.4, Ar–H),
3.44 (s, 9H, –OCH3), 3.24 (s, 1H, –NH), 3.13 (s, 1H, –NH),
2.57 (d, 2H, J= 1.6, –CH2), 4.5 (t, 2H, –CH).
N2-[2-Chloro-4(3,4,5-trimethoxy phenyl)azetidin-1-yl]-N4-
(4-nitro phenyl)-1,3-thiazole-2,4-diamine (4b): IR (KBr
cm1): 1111 (C–S), 1600 (C‚C), 3361 (NO), 3478 (NH). 1H
NMR (CDCl3) d (ppm): 7.93 (s, 2H, Ar–H), 6.59 (d, 2H,
J= 8.4, Ar–H), 6.72 (d, 2H, J= 8.4, Ar–H), 3.34 (s, 1H,
NH), 4.68 (s, 1H, –CH), 5.15 (s, 1H, NH), 3.36 (s, 9H,
–OCH3) 2.48 (d, 2H, J= 1.58, –CH2).
N2-[2-Chloro-4(3,4,5-trimethoxy phenyl)azetidin-1-yl]-N4-
(4-ethyl acetate phenyl)-1,3-thiazole-2,4-diamine (4c): IR
(KBr cm1): 1101 (C‚S), 744 (C–Cl), 1160 (C‚C), 3422
(NH). 1H NMR (CDCl3) d (ppm): 7.61 (s, 2H, Ar–H), 6.53
(d, 2H, J= 8.4 Hz, Ar–H), 7.58 (d, 2H, J= 8.4 Hz, Ar–H),
5.92 (s, 2H, NH), 4.18 (t, 1H, –CH), 6.51 (s, 1H, –CH), 2.47
(d, 2H, J= 1.6 Hz, –CH2), 3.30 (s, 9H, –OCH3).
N2-[2-Chloro-4(3,4,5-trimethoxy phenyl)azetidin-1-yl]-N4-
(4-hydroxy phenyl)-1,3-thiazole-2,4-diamine (4d): IR (KBr
cm1): 1101 (C‚S), 744 (C–Cl), 1160 (C‚C), 3422 (NH),
3303 (–OH). 1H NMR (CDCl3) d (ppm): 7.52 (s, 2H, Ar–H),
6.67 (d, 2H, J= 8.4 Hz, Ar–H), 7.71 (d, 2H, J= 8.4 Hz,
Ar–H), 5.83 (s, 2H, NH), 4.28 (t, 1H, –CH), 6.51 (s, 1H,
–CH), 2.41 (d, 2H, J= 1.6 Hz, –CH2), 3.30 (s, 9H, –OCH3).
4-[(2-{[2-Chloro-4-(3,4,5-trimethoxy phenyl)azetidin-1-yl]-
amino}-1,3-thiazol-4-yl) amino] benzoic acid (4e): IR (KBr
cm1): 1035 (C–S), 1172 (C‚C), 3370 (OH), 2940 (CH). 1H
NMR (CDCl3) d (ppm): 7.60 (s, 2H, Ar–H), 6.53 (d, 2H,
J= 8.4 Hz, Ar–H), 7.89 (d, J= 8.4 Hz, 2H, Ar–H), 5.88 (s,
1H, –CH), 11.96 (br s, 1H, –OH), 3.97 (br s, 1H, NH), 3.06
(s, 9H, –OCH3), 2.57 (d, 2H, J= 1.6 Hz, –CH2), 4.58 (t, 1H,
–CH).
N2-[2-Chloro-4(3,4,5-trimethoxy phenyl)azetidin-1-yl]-N4-
(4-ethyl phenyl)-1,3-thiazole-2,4-diamine (4f): IR (KBr
cm1): 1035 (C–S), 1176 (C‚C), 2940 (CH). 1H NMR
(CDCl3) d (ppm): 6.89 (d, 2H, J= 8.4, Ar–H), 7.21 (d, 2H,
J= 8.4, Ar–H) 7.48 (s, 2H, Ar–H), 5.72 (s, 1H, NH), 4.23
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3.32 (s, 9H, –OCH3), 2.01 (m, 2H, –CH2), 1.5 (t, 3H, –CH3).
N2-[2-Chloro-4(3,4,5-trimethoxy phenyl)azetidin-1-yl]-N4-
phenyl-1,3-thiazole-2,4-diamine (4g): 1182 (C‚C), 1045
(C–S), 2930 (CH). 1H NMR (CDCl3) d (ppm): 7.44 (s, 2H,
Ar–H), 6.84 (d, 2H, J= 8.3, Ar–H), 7.21 (t, 3H, Ar–H) 4.72
(s, 1H, NH), 4.23 (t, 1H, CH), 2.47 (d, 2H, J= 1.6, –CH2),
6.7 (s, 1H, –CH), 3.21, 6.12 (s, 1H, –NH), (s, 9H, –OCH3).
Mass (GC–MS) [m/z, %]: 441; 348 (93), 317 (31), 303 (14),R
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Scheme 1 (a) Methanol, (b) chloracetyl chloride, methanol, (c) triet
ethanol.267 (36), 229 (28), 208 (31), 192 (16), 161 (33), 147 (14), 116
(30), 101 (14), 86 (14).
2.2. In vitro antioxidant activity of thiazole derivatives
2.2.1. Scavenging of nitric oxide radical
Sodium nitroprusside in aqueous solution at physiological pH
spontaneously generates nitric oxide, which interacts with oxy-
gen to produce nitrite ions, which can be estimated by the useNH
S
NH2
N H2
Thiosemicarbazide
N
Cl
NH2
S
micarbazone
enyl)hydrazinyl]-1,3-thiazoles 
N
S
Cl
nyl)azetidin-1-yl]-1,3-thiazole-2-amine 
N
S
R3
l]-N4-(substituted aryl)-1,3-thiazole-2,4-diamine
hyl amine, chloracetyl chloride, methanol, (d) secondary amines,
Table 1 Various substitutions on thiazole ring.
Compounds R R1 R2 R3
3 –OCH3 –OCH3 –OCH3 –Cl
4a –OCH3 –OCH3 –OCH3 –NHC6H4 o-NO2
4b –OCH3 –OCH3 –OCH3 –NHC6H4 p-NO2
4c –OCH3 –OCH3 –OCH3 –NHC6H4COOC2H5
4d –OCH3 –OCH3 –OCH3 –NHC6H4OH
4e –OCH3 –OCH3 –OCH3 –NHC6H4COOH
4f –OCH3 –OCH3 –OCH3 –NHC6H4C2H5
4g –OCH3 –OCH3 –OCH3 –NHC6H4
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Scavengers of nitric oxide compete with oxygen leading to re-
duce production of nitric oxide. The reaction mixture (6 ml)
containing sodium nitroprusside (10 mM, 4 ml), phosphate
buffer saline (PBS, pH 7.4, 1 ml) and thiazole derivatives (3
and 4a–g) or standard (1 ml) in DMSO at various concentra-
tions was incubated at 25 C for 150 min. After incubation,
0.5 ml of the reaction mixture containing nitrite ion was re-
moved, 1 ml of sulphanilic acid reagent was added, mixed well
and allowed to stand for 5 min for completion of diazotisation.
Then 1 ml of NEDD was added, mixed and allowed to stand
for 30 min in diffused light. A pink coloured chromophore
was formed. The absorbance was measured at 540 nm (Jaish-
ree and Badami, 2009).
2.2.2. Scavenging of hydrogen peroxide
Hydrogen peroxide is generated in vivo by several oxidase en-
zymes. There is increasing evidence that hydrogen peroxide,
either directly or indirectly via its reduction product hydroxyl
radical (OHÆ) causes severe damage to biological systems. In
this method, when a scavenger is incubated with hydrogen per-
oxide, the decay or loss of hydrogen peroxide can be measured
spectrophotometrically at 230 nm (Jayaprakasha et al., 2004).
The method was carried out with minor modiﬁcations. A solu-
tion of hydrogen peroxide (20 mM) was prepared in phosphate
buffered saline (PBS, pH 7.4). Various concentrations of 1 ml
of the thiazole derivatives (3 and 4a–g) or standards in meth-
anol were added to 2 ml of hydrogen peroxide solution in
PBS. The absorbance was measured at 230 nm after 10 min.
2.2.3. Lipid peroxidation inhibitory activity
Lipid peroxidation can be initiated by ROS such as hydroxyl
radicals by extracting a hydrogen atom from lipids and form-
ing a conjugated lipid radical. This reacts rapidly with oxygen
to form a lipid radical until the chain reaction is terminated.
The lipid peroxidation adducts may induce the oxidation of
biomolecules, such as DNA, proteins and other lipids, result-
ing in cellular damage. The method was followed by Diplock
with minor modiﬁcations. The reaction mixture containing
(1 ml) egg lecithin, (0.02 ml) ferric chloride, (0.02 ml) ascorbic
acid and thiazole derivatives (3 and 4a–g) or standard (0.1 ml)
in DMSO at various concentrations, kept for incubation for
1 h at 37 C. After incubation, 2 ml of 15% TCA and 2 ml
of 0.375% TBA were added. Then the reaction mixture was
boiled for 15 min, cooled and centrifuged. The absorbance of
supernatant was measured at 532 nm (Diplock et al., 1994).
2.2.4. Reducing power determination of thiazole derivatives
This method is based on the principle of increase in the absor-
bance of the reaction mixture. Increase in absorbance indicates
increase in the antioxidant activity. In this method antioxidant
compounds form a coloured complex with potassium ferricya-
nide, trichloro acetic acid and ferric chloride and measured at
700 nm. Increase in absorbance of the reaction mixture indi-
cates the reducing power of the samples. The reducing power
of test samples was determined according to the method of
Oyaizu. The standard drugs and thiazole derivatives (3 and
4a–g) were dissolved in dimethyl formamide (DMF) to get dif-
ferent concentrations. This was mixed with 2.5 ml of (pH 6.6)
0.2 M phosphate buffer and 2.5 ml of 1% potassium ferricya-
nide. The mixture was incubated at 50 C for 20 min. 2.5 ml of
10% trichloroacetic acid was added to the mixture, which wasthen centrifuged for 10 min at 1000 rpm. 2.5 ml upper layer of
the solution was mixed with 2.5 ml of distilled water and 0.5 ml
of 0.1% ferric chloride. The absorbance was measured at
700 nm. The blank was also carried out in similar manner.
The activity was compared with ascorbic acid, which was used
as a standard antioxidant (Oyaizu, 1986).
3. Results and discussion
3.1. Chemistry
The synthetic route of the compounds is outlined in Scheme 1.
3,4,5-Trimethoxy benzaldehyde was condensed with thiosemi-
carbazide to obtain corresponding 3,4,5-trimethoxy benzalde-
hyde thiosemicarbazone (1). Cyclization of (1) with chlo-
racetyl chloride yielded corresponding thiazolyl hydrazone (2).
Compound (2) was cyclised with chloracetyl chloride and trieth-
ylamine to obtain the corresponding 4-chloro-N-[2-chloro-
4(3,4,5-trimethoxy phenyl) azetidin-1-yl]-1,3-thiazol-2-amine
(3). Various substitutions on compound 3 with secondary
amines yielded series of compounds (4a–g). The structure of
the synthesized compounds was conﬁrmed by analytical (Tables
1 and 2) and IR, 1H NMR and GC–MS spectral data.
3.2. In vitro antioxidant activity
All the compounds were tested for their in vitro antioxidant
activity, such as nitric oxide, hydrogen peroxide free radicals
scavenging activities and lipid peroxidation inhibitory activity
and reducing capacity of the compounds. The investigation of
antioxidant screening revealed that all the newly synthesized
compounds showed potent to moderate radical scavenging
activity when compared to the standard ascorbic acid.
The antioxidant activities are shown in Table 3 and com-
pound 4c possessed potent inhibitory activity against nitric
oxide free radical with IC50 value of 28 ± 0.01 lg/ml when
compared to the standard ascorbic acid 32 ± 0.09 lg/ml.
Compound 4 g showed mild inhibitory activity against nitric
oxide free radical scavenging activity with IC50 value of
38 ± 0.08 lg/ml. In hydrogen peroxide scavenging activity as-
say, compounds 4e and 4d have shown strong inhibitory effect
with IC50 values of 21 ± 0.23 and 24 ± 0.07 lg/ml, respec-
tively. The compounds proved to be more active than the stan-
dard ascorbic acid (IC50; 36 ± 0.81 lg/ml). However,
compounds 4c and 4f showed mild inhibitory effect in the
hydrogen peroxide radical scavenging activity. Compounds
4e, 4f and 4c exhibited potent antioxidant effect against lipid
peroxide with IC50 values of 11 ± 0.45, 18 ± 0.09 and
Table 3 IC50 values of N2-[2-chloro-4(3,4,5-trimethoxy phenyl) azetidin-1-yl)]-N4-(substituted aryl)-1,3-thioazole-2,4-diamine (3 and
4a–g) compounds.
Compounds/standard IC50 ± S.D.
* (lg/ml)
Nitric oxide Hydrogen peroxide Lipid peroxidation
3 <100 <100 35 ± 0.34
4a <100 <100 95 ± 0.32
4b <100 <100 80 ± 0.04
4c 28 ± 0.01 40 ± 0.01 21 ± 0.17
4d 61 ± 0.10 24 ± 0.07 <100
4e <100 21 ± 0.23 11 ± 0.45
4f 91 ± 0.04 43 ± 0.65 18 ± 0.09
4g 38 ± 0.08 <100 40 ± 0.11
Ascorbic acid 32 ± 0.09 36 ± 0.81 35 ± 0.02
* Average of three determinations.
Table 4 Reducing power of N2-[2-chloro-4(3,4,5-trimethoxy phenyl) azetidin-1-yl)]-N4-(substituted aryl)-1,3-thioazol-2,4-diamine (3
and 4a–g) compounds.
Compounds/standard Absorbance value ± S.D.* (lg/ml)
12.5 25 50 100
3 1.50 ± 0.18 1.59 ± 0.16 1.61 ± 0.09 1.62 ± 0.20
4a 1.81 ± 0.12 1.80 ± 0.17 1.71 ± 0.01 1.82 ± 0.08
4b 1.54 ± 0.03 1.66 ± 0.08 1.67 ± 0.05 1.71 ± 0.01
4c 1.09 ± 0.07 1.15 ± 0.04 1.12 ± 0.08 1.25 ± 0.03
4d 1.03 ± 0.03 1.12 ± 0.06 1.40 ± 0.07 1.81 ± 0.04
4e 1.04 ± 0.04 1.22 ± 0.05 1.51 ± 0.08 1.88 ± 0.07
4f 1.11 ± 0.09 1.44 ± 0.08 1.61 ± 0.09 1.77 ± 0.06
4g 0.81 ± 0.02 1.12 ± 0.02 1.41 ± 0.02 1.81 ± 0.30
Ascorbic acid 0.33 ± 0.01 0.59 ± 0.02 0.86 ± 0.01 1.36 ± 0.03
* Average of three determinations.
Table 2 Characterization data of N2-[2-chloro-4(3,4,5-trimethoxy phenyl) azetidin-1-yl)]-N4-(substituted aryl)-1,3-thioazole-2,4-
diamine (3 and 4a–g) compounds.
Compounds Molecular formula MW M.P. (C) Yield (%) % Analysis of CHN found (calculated)
C H N
3 C15H17Cl2N3O3S 388 190 48 46.16 (46.27) 04.39 (04.37) 10.75 (10.79)
4a C21H22ClN5O5S 491 201 78 – – –
4b C21H22ClN5O5S 492 209 75 51.26 (51.21) 04.52 (04.47) 14.26 (14.22)
4c C24H27ClN4O5S 518 211 80 55.53 (55.49) 05.25 (05.20) 10.79 (10.78)
4d C21H23ClN4O4S 464 199 44 – – –
4e C22H23ClN4O5S 491 191 65 53.80 (53.74) 04.71 (04.68) 11.42 (11.40)
4f C23H27ClN4O3S 474 202 67 – – –
4g C21H23ClN4O3S 447 195 52 – – –
In vitro antioxidant properties of new thiazole derivatives 37521 ± 0.17 lg/ml, respectively. All other compounds have
shown mild inhibitory effect in lipid peroxidation assay. In
reducing power assay all the synthesized compounds have
shown the highest reducing ability than the standard ascorbic
acid (Table 4).
This study provides evidence that all thiazole derivatives
possessed interesting antioxidant properties, which was ex-
pressed by their inhibitory effect on the nitric oxide radical
scavenging, hydrogen peroxide and lipid peroxidation inhibi-
tory assays. The acetyl and carboxylic groups’ substitutionderivatives have shown potent antioxidant activity in all the
tested methods. On the other hand, lower antioxidant activity
was found in ortho- and para-nitro substituted derivatives.
The reducing ability increases with increasing absorbance.
All thiazole derivatives exhibited better reducing ability when
compared with the standard ascorbic acid. It conﬁrms all com-
pounds are having capacity to reduce ferric to ferrous ion.
In conclusion, the present study suggests that the synthe-
sized thiazole derivatives can scavenge radicals of biological
interest and prevents damage of proteins and lipids. Our
376 V. Jaishree et al.studies, hence, reveal that thiazole derivatives exhibited evi-
dent antioxidant properties in vitro.
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